Advertisement
Review Article| Volume 55, SUPPLEMENT 2, S13-S19, October 2006

The pharmacology of wakefulness

      Abstract

      Being awake, alert, and able to function in our 24-7 world is a challenge in the face of the fatigue and sleepiness engendered by long work hours, unusual work schedules, sickness, and other factors. Development of effective treatments to combat fatigue and sleepiness requires an understanding of the neurobiology of wakefulness. In this brief review, we examine the neuroanatomical, neurochemical, and molecular basis of the wakeful state to provide a framework for understanding current and future pharmacologic approaches to modification of wakefulness. The spontaneously awake state can be defined as a natural state of vigilance or arousal differing from natural sleep in both behavior and neural activity. These differences have long intrigued researchers and largely have been characterized in the brain areas and neurochemical systems affecting the sleep and wake states. Many of the strategies for promoting the awake condition involve manipulation or modulation of specific neurochemical systems with the ultimate goal of enhancing wakefulness, diminishing sleepiness, or both. Wakefulness is an important cortical function that depends on the coordinated effort of multiple brain areas including the thalamus, hypothalamus, and basal forebrain to integrate and relay information from the brainstem to the cortex. Norepinephrine and serotonin—long considered arousal-enhancing transmitters as well as glutamate, acetylcholine, histamine, and the neuromodulators hypocretin-orexins and adenosine, are known to affect the signal transduction in these brain areas and initiate, promote, or enhance wakefulness. Use of molecular tools to evaluate the awake, asleep, and sleep-deprived state has revealed novel insights concerning the gene expression events associated with wakefulness. Understanding wakefulness at this level undoubtedly will contribute to the development of pharmacologic approaches to promote or enhance the wakeful state. We caution, however, that sleep may have a necessary, restorative function for the brain; therefore, prolonging wakefulness for long periods through artificial means could have unexpected and perhaps detrimental consequences on brain health.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schultz D.
        • Miller J.C.
        Fatigue and use of go/no-go pills in extraordinarily long combat sorties.
        Aviat Space Environ Med. 2004; 75: 370-371
        • Antle M.C.
        • Silver R.
        Orchestrating time: arrangements of the brain's circadian clock.
        Trends Neurosci. 2005; 28: 145-151
        • Hobson J.A.
        • Pace-Schott E.F.
        Sleep, dreaming, and wakefulness.
        in: Squire L.R. Bloom F.E. McConnell S.K. Roberts J.L. Spitzer N.C. Zigmond M.J. Fundamental neuroscience, second edition. Academic Press, Amsterdam2003: 1085-1108
        • Caldwell J.A.
        • Smith J.K.
        • Caldwell J.L.
        • et al.
        Are individual differences in fatigue vulnerability related to baseline differences in cortical activation.
        Behav Neurosci. 2005; 119: 694-707
        • Siegel J.M.
        Clues to the functions of mammalian sleep.
        Nature. 2005; 437: 1264-1271
        • Walker M.P.
        • Stickgold R.
        Sleep, memory, and plasticity.
        Annu Rev Psychol. 2006; 57: 139-166
        • Nofzinger E.A.
        Neuroimaging and sleep medicine.
        Sleep Med Rev. 2005; 9: 157-172
        • Ancoli-Israel S.
        • Cole R.
        • Alessi C.
        • Chambers M.
        • Moorcroft W.
        • Pollak C.P.
        The role of actigraphy in the study of sleep and circadian rhythms.
        Sleep. 2003; 26: 342-392
        • Barinaga M.
        What makes brain neurons run?.
        Science. 1997; 276: 196-198
        • Porkka-Heiskanen T.
        Gene expression during sleep, wakefulness and sleep deprivation.
        Front Biosci. 2003; 8: s421-s437
        • Cirelli C.
        • LaVaute T.M.
        • Tononi G.
        Sleep and wakefulness modulate gene expression in Drosophila.
        J Neurochem. 2005; 94: 1411-1419
        • Shaw P.J.
        • Tononi G.
        • Greenspan R.J.
        • Robinson D.F.
        Stress response genes protect against lethal effects of sleep deprivation in Drosophila.
        Nature. 2002; 417: 287-291
        • Jones B.E.
        From waking to sleeping: neuronal and chemical substrates.
        Trends Pharmacol Sci. 2005; 26: 578-586
        • Giles J.
        Alertness drug arouses fears about ‘lifestyle’ misuse.
        Nature. 2005; 436: 1076
        • Porrino L.J.
        • Daunais J.B.
        • Rogers G.A.
        • Hampson R.E.
        • Deadwyler S.A.
        Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.
        Plos Biol. 2005; 3: 1639-1652
        • Boutrel B.
        • Koob G.F.
        What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
        Sleep. 2004; 27: 1181-1194
        • Espana R.A.
        • Scammell T.E.
        Sleep neurobiology for the clinician.
        Sleep. 2004; 27: 811-820
        • Siegel J.M.
        Hypocretin (orexin): role in normal behavior and neuropathology.
        Annu Rev Psychol. 2004; 55: 125-148
        • Wisor J.P.
        • Kilduff T.S.
        Molecular genetic advances in sleep research and their relevance to sleep medicine.
        Sleep. 2005; 28: 357-367
        • Basheer R.
        • Strecker R.E.
        • Thakkar M.M.
        • McCarley R.W.
        Adenosine and sleep-wake regulation.
        Prog Neurobiol. 2004; 73: 379-396
        • Huang Z.-L.
        • Qu W.-M.
        • Eguchi N.
        • Chen J.-F.
        • et al.
        Adenosine A2a, but not A1, receptors mediate the arousal effect of caffeine.
        Nat Neurosci. 2005; 8: 858-859
        • Wesensten N.J.
        • Belenky G.
        • Kautz M.A.
        • et al.
        Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
        Psychopharmacol. 2002; 159: 238-247
        • Wyatt J.K.
        • Cajochen C.
        • Ritz-De Cecco A.
        • Czeisler C.A.
        • Dijki D.J.
        Low-dose repeated caffeine administration for circadian-phase–dependent performance degradation during extended wakefulness.
        Sleep. 2004; 27: 374-381
        • Cirelli C.
        A molecular window on sleep: changes in gene expression between sleep and wakefulness.
        Neuroscientist. 2005; 11: 63-74
        • Terao A.
        • Steininger T.L.
        • Hyder K.
        • et al.
        Differential increase in the expression of heat shock protein family members during sleep deprivation and during sleep.
        Neurosci. 2003; 116: 187-200
      1. O'Connor A. Wakefulness finds a powerful ally. Science Times NY Times, June 29, 2004.

        • Hendricks J.C.
        Shaking up sleep research.
        Nat Neurosci. 2005; 8: 703-705
        • Virtanen S.V.
        • Notkola V.
        Socioeconomic inequalities in cardiovascular mortality and the role of work: a register study of Finnish men.
        Int J Epidemiol. 2002; 31: 614-621
        • Naidoo N.
        • Giang W.
        • Galante R.J.
        • Pack A.I.
        Sleep deprivation induces the unfolded protein response in mouse cerebral cortex.
        J Neurochem. 2005; 92: 1150-1157
        • Majumdar S.
        • Mallick B.N.
        Cytomorphometric changes in rat brain neurons after rapid eye movement sleep deprivation.
        Neurosci. 2005; 135: 679-690
        • Cirelli C.
        • Shaw P.J.
        • Rrechtschaffen A.
        • Tononi G.
        No evidence of brain cell degeneration after long-term sleep deprivation in rats.
        Brain Res. 1999; 840: 184-193
        • Eiland M.M.
        • Ramanathan L.
        • Gulyani S.
        • Gilliland M.
        • Bergmann B.M.
        • Rechtschaffen A.
        • et al.
        Increases in amino cupric silver staining of the supraoptic nucleus after sleep deprivation.
        Brain Res. 2002; 945: 1-8
        • Hsu J.-C.
        • Lee Y.-S.
        • Chang C.-N.
        • Ling E.-A.
        • Lan C.-T.
        Sleep deprivation prior to transient global cerebral ischemia attenuates glial reaction in the rat hippocampal formation.
        Brain Res. 2003; 984: 170-181
        • Hairston I.S.
        • Little M.T.
        • Scanlon M.D.
        • et al.
        Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning.
        J Neurophysiol. 2005; 94: 4224-4233